NCT04657991 2026-04-07A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic MelanomaPfizerPhase 3 Active not recruiting257 enrolled
NCT05203172 2026-04-07The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical TrialsPfizerPhase 4 Recruiting46 enrolled